A cross-sectional comparative study of the monocyte to high-density lipoprotein cholesterol ratio in normal individuals, type 2 diabetes mellitus, and diabetic nephropathy.
DOI:
https://doi.org/10.51168/sjhrafrica.v6i6.1845Keywords:
Monocyte to High-Density Lipoprotein Ratio, Diabetes Mellitus, Diabetic Nephropathy, Inflammation, High-Density Lipoprotein Cholesterol, Renal Function, BiomarkerAbstract
Background
Chronic low-grade inflammation plays a pivotal role in the progression of diabetes mellitus and its complications, particularly diabetic nephropathy. The Monocyte to HDL Cholesterol Ratio (MHR) has emerged as a novel inflammatory marker linked with cardiovascular and metabolic disorders. However, its clinical relevance across the spectrum of diabetes and nephropathy remains underexplored.
Objective: To compare the MHR among healthy individuals, patients with type 2 diabetes mellitus, and those with diabetic nephropathy, and to evaluate its correlation with renal function markers.
Methods
A cross-sectional comparative study was conducted among 100 participants divided into three groups: healthy controls (n = 30), diabetes mellitus without complications (n = 35), and diabetic nephropathy (n = 35). Monocyte count, HDL cholesterol levels, and renal function tests (serum creatinine, eGFR) were measured. MHR was calculated as the ratio of absolute monocyte count to HDL cholesterol. Statistical analysis was done using ANOVA and Pearson’s correlation.
Results
The mean age of participants was 52.9 ± 7.7 years, with no statistically significant age difference among groups. Gender distribution was approximately balanced (55% male, 45% female).MHR values showed a progressive increase from healthy individuals (8.45 ± 1.56) to diabetic patients (13.27 ± 2.31), and were highest in diabetic nephropathy patients (18.65 ± 3.02) (p < 0.001). MHR was positively correlated with serum creatinine (r = 0.52, p < 0.01) and negatively with eGFR (r = -0.47, p < 0.01). Significant intergroup differences were observed across all parameters.
Conclusion
The study highlights that MHR significantly increases with disease progression from diabetes to diabetic nephropathy and correlates with declining renal function. MHR may serve as a simple, cost-effective inflammatory biomarker for early risk stratification in diabetic patients.
Recommendations
Routine inclusion of MHR in diabetic monitoring protocols may improve early detection of nephropathy and guide timely interventions in high-risk individuals.
References
Tang X, Tan Y, Yang Y, Li M, He X, Lu Y, et al. Association of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy. Front Cardiovasc Med. 2021 Sep 21;8:707008. https://doi.org/10.3389/fcvm.2021.707008 PMid:34621797 PMCid:PMC8490616
Onalan E. The relationship between the monocyte to high-density lipoprotein cholesterol ratio and diabetic nephropathy. Pak J Med Sci. 2019 Jul-Aug;35(4):1081-1086. doi: 10.12669/pjms.35.4.534. PMID: 31372147; PMCID: PMC6659096.
Zhang H, Lu J, Gao J, Sha W, Cai X, Rouzi MRYM, et al. Association of Monocyte-to-HDL Cholesterol Ratio with Endothelial Dysfunction in Patients with Type 2 Diabetes. J Diabetes Res. 2024 Jan 11;2024:5287580. https://doi.org/10.1155/2024/5287580 PMid:38239233 PMCid:PMC10796180
Mayasari DS, Taufiq N, Hariawan H. Association of monocyte-to-high-density lipoprotein ratio with arterial stiffness in patients with diabetes. BMC Cardiovasc Disord. 2021 Jul 30;21(1):362. https://doi.org/10.1186/s12872-021-02180-6 PMid:34330221 PMCid:PMC8325234
Jia J, Liu R, Wei W, Yu F, Yu X, Shen Y,et al. Monocyte to High-Density Lipoprotein Cholesterol Ratio at the Nexus of Type 2 Diabetes Mellitus Patients With Metabolically Associated Fatty Liver Disease. Front Physiol. 2021 Dec 17;12:762242. https://doi.org/10.3389/fphys.2021.762242 PMid:34975521 PMCid:PMC8718696
Sener A, Hatil SI, Erdogan E, Durukan E, Topcuoglu C. Monocyte-to-HDL cholesterol ratio and uric acid-to-HDL cholesterol ratio as predictors of vitamin D deficiency in healthy young adults: a cross-sectional study. Arch Endocrinol Metab. 2024 Aug 27;68:e240004. https://doi.org/10.20945/2359-4292-2024-0004 PMid:39420939 PMCid:PMC11460974
Yang W, Zhong Y, Zhou P, Lu D. Monocyte to high-density lipoprotein cholesterol ratio as a marker of the presence and progression of diabetic kidney disease. Ren Fail. 2025 Dec;47(1):2438846. https://doi.org/10.1080/0886022X.2024.2438846 PMid:39806776 PMCid:PMC11734387
Karatas A, Turkmen E, Erdem E, Dugeroglu H, Kaya Y. Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy. Biomark Med. 2018 Sep;12(9):953-959. https://doi.org/10.2217/bmm-2018-0048 PMid:30043636
D Y, Sk SR, R NK, Pa A. Association Between Monocyte-to-High-Density Lipoprotein (HDL) Cholesterol Ratio and Proteinuria in Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study. Cureus. 2023 Sep 22;15(9):e45783. https://doi.org/10.7759/cureus.45783 PMID: 37872916; PMCID: PMC10590622.
Efe FK. The association between monocyte HDL ratio and albuminuria in diabetic nephropathy. Pak J Med Sci. 2021 Jul-Aug;37(4):1128-1132. https://doi.org/10.12669/pjms.37.4.3882 PMid:34290795 PMCid:PMC8281181
Djesevic M, Hasic S, Lepara O, Jahic R, Kurtovic A, Fajkic A. CRP/HDL-C and Monocyte/HDL-C Ratios as Predictors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus. Acta Inform Med. 2023;31(4):254-259. https://doi.org/10.5455/aim.2023.31.254-259 PMid:38379696 PMCid:PMC10875961
Li C, Fan H, Liu Y, Zeng L, Chen P, Duan C, et al. The monocyte to high-density lipoprotein cholesterol ratio and outcomes in type 2 diabetes mellitus patients with non-ST-segment elevation acute coronary syndrome. Ann Transl Med. 2021 Nov;9(21):1627. https://doi.org/10.21037/atm-21-4876 PMid:34926671 PMCid:PMC8640916
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr. Shaik Yaseen Chand Basha, Dr.M.Sarala, Daya Truphosa Devara, M.Prasad

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.